Newsletter

Subscribe and recieve updates on this company.

Text STOCKS to 72727 for mobile alerts

We are excited to present Neurocrine Biosciences, Inc. (NASDAQ: NBIX).

Full DD Report for NBIX

You must become a subscriber to view this report.


Recent News from (NASDAQ: NBIX)

Neurocrine Biosciences to Present at the Morgan Stanley 16th Annual Global Healthcare Conference
SAN DIEGO , Sept. 5, 2018 /PRNewswire/ -- Neurocrine Biosciences, Inc. (NASDAQ: NBIX) will present at the Morgan Stanley 16 th Annual Global Healthcare Conference at 8:10 a.m. ET on Wednesday, Sept. 12, 2018 , in New York City . Kevin Gorman , Chief Executive Officer of Neurocrine Bio...
Source: PR Newswire
Date: September, 05 2018 16:01
Small Caps Are Rising, Biotechs Can't Be Far Behind
Market Pulse The S&P 500 has finally emerged from its 7-month consolidation as it weaves its way back to chalking all-time highs. While that is an event worth acknowledging, it may not be as breathless a milestone when one realizes that the small cap Russell 2000 index led the market and...
Source: SeekingAlpha
Date: September, 05 2018 13:31
Neurocrine Biosciences: This Is Only The Beginning
Editor's note: Seeking Alpha is proud to welcome William Wellings as a new contributor. It's easy to become a Seeking Alpha contributor and earn money for your best investment ideas. Active contributors also get free access to the SA PRO archive. Click here to find out more » Company...
Source: SeekingAlpha
Date: August, 24 2018 12:28
Premarket analyst action - healthcare
ACADIA Pharmaceuticals (NASDAQ: ACAD ) initiated with Overweight rating and $25 (79% upside) price target at Cantor Fitzgerald. Shares up  3%  premarket. More news on: ACADIA Pharmaceuticals Inc., Alder Biopharmaceuticals Inc., Halozyme Therapeutics, Inc., Healthcare stocks news,...
Source: SeekingAlpha
Date: August, 23 2018 08:21

 


Last 5 Days Trading Activity

DateOpen PriceClose PriceHighLowVolume
2018-10-29108.83104.87110.00103.33946,625
2018-10-26103.99107.22108.495102.34618,867
2018-10-25102.68106.14108.18102.04868,692
2018-10-24108.62101.85108.63101.472826,857
2018-10-23107.00108.56109.2049105.48716,248

Last 5 Days Short Activity

DateShort VolumeTotal VolumeShort PercentageShort Indicator
2018-12-14163,017623,35726.1515Cover
2018-12-13365,854868,90242.1053Short
2018-12-121,262,6194,104,21830.7639Cover
2018-12-11102,974152,43667.5523Short
2018-12-1052,830116,79745.2323Short

* Short Mode

Short Analysis provided by Squeeze Report. Get a complete short report on NBIX.


About Neurocrine Biosciences, Inc. (NASDAQ: NBIX)

Logo for Neurocrine Biosciences, Inc. (NASDAQ: NBIX)

Not available

 

Contact Information

 

 

Current Management

  • Gary A. Lyons / President, CEO
  • Paul W. Hawran / CFO

Current Share Structure

  • Market Cap: $8,382,975,725 - 05/18/2018
  • Issue and Outstanding: 89,897,863 - 04/25/2018

 


Recent Filings from (NASDAQ: NBIX)

Securities offered to employees under employee benefit plans
Filing Type: S-8Filing Source: edgar
Filing Date: August, 22 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: August, 03 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: July, 31 2018
Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: July, 31 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: July, 24 2018
Filing Type: CT ORDERFiling Source: edgar
Filing Date: June, 05 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: May, 30 2018
Filing Type: CT ORDERFiling Source: edgar
Filing Date: May, 08 2018
Report of unscheduled material events or corporate changes.
Filing Type: 8-KFiling Source: edgar
Filing Date: April, 30 2018
Quarterly report with a continuing view of a company's financial position
Filing Type: 10-QFiling Source: edgar
Filing Date: April, 30 2018

 

 


Daily Technical Chart for (NASDAQ: NBIX)

Daily Technical Chart for (NASDAQ: NBIX)


Stay tuned for daily updates and more on (NASDAQ: NBIX)

It most certainly could but even more important is the recent overwhelming interest in the company. Check out Investors Hub and search on Twitter

More to come on (NASDAQ: NBIX)

Do your DD and if you choose, be ready to go!


 

The Research: All source information contained in this email is from the public sources mentioned below.

 

 
 

Thank you

DD Report
@DDReports

 

 


Disclaimer: DD Report publishes reports providing information on selected companies. DD Report is not a registered investment advisor or broker-dealer. This report is provided as an information service only, and the statements and opinions in this report should not be construed as an offer or solicitation to buy or sell any security. DD Report accepts no liability for any loss arising from an investors reliance on or use of this report. An investment in NBIX is considered to be highly speculative and should not be considered unless a person can afford a complete loss of investment. DD Report has received no compensation for the publication and circulation of this report. DD Report does not own any shares of NBIX and does not buy, sell, or trade any shares of NBIX. This report contains forward-looking statements, which involve risks, and uncertainties that may cause actual results to differ materially from those set forth in the forward-looking statements. Copyright 2018 by DD Report. All rights reserved. Our Full Disclaimer: https://dd.report/disclaimer/